These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14534918)

  • 1. Impact of placebo assignment in clinical trials of Parkinson's disease.
    Goetz CG; Janko K; Blasucci L; Jaglin JA
    Mov Disord; 2003 Oct; 18(10):1146-9. PubMed ID: 14534918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How placebos change the patient's brain.
    Benedetti F; Carlino E; Pollo A
    Neuropsychopharmacology; 2011 Jan; 36(1):339-54. PubMed ID: 20592717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Better to be in The Placebo Arm for Trials of Neurological Therapies?
    Kimmelman J
    Cell Transplant; 2018 Apr; 27(4):677-681. PubMed ID: 29855198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis and validation of a Parkinson's disease register as a recruitment tool for clinical studies.
    Carroll C; Palmer A; Cosby C; Zajicek J
    Clin Med (Lond); 2012 Jun; 12(3):210-5. PubMed ID: 22783770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding and harnessing placebo effects: clearing away the underbrush.
    Miller FG; Brody H
    J Med Philos; 2011 Feb; 36(1):69-78. PubMed ID: 21220523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual Reality Rehabilitation Versus Conventional Physical Therapy for Improving Balance and Gait in Parkinson's Disease Patients: A Randomized Controlled Trial.
    Feng H; Li C; Liu J; Wang L; Ma J; Li G; Gan L; Shang X; Wu Z
    Med Sci Monit; 2019 Jun; 25():4186-4192. PubMed ID: 31165721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions.
    Goetz CG; Wuu J; McDermott MP; Adler CH; Fahn S; Freed CR; Hauser RA; Olanow WC; Shoulson I; Tandon PK; ; Leurgans S
    Mov Disord; 2008 Apr; 23(5):690-9. PubMed ID: 18228568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Clinical Trial of Isradipine: What Went Wrong?
    Maiti B; Perlmutter JS
    Ann Intern Med; 2020 May; 172(9):625-626. PubMed ID: 32227234
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of bilateral subthalamic nucleus DBS in Parkinson's disease in young versus old: A single institutional study.
    Vats A; Amit A; Doshi P
    J Clin Neurosci; 2019 Dec; 70():85-91. PubMed ID: 31481291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease.
    Monti DA; Zabrecky G; Kremens D; Liang TW; Wintering NA; Bazzan AJ; Zhong L; Bowens BK; Chervoneva I; Intenzo C; Newberg AB
    Clin Pharmacol Ther; 2019 Oct; 106(4):884-890. PubMed ID: 31206613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor and non-motor outcomes in patients with advanced Parkinson's disease treated with levodopa/carbidopa intestinal gel: final results of the GREENFIELD observational study.
    Lopiano L; Modugno N; Marano P; Sensi M; Meco G; Solla P; Gusmaroli G; Tamma F; Mancini F; Quatrale R; Zangaglia R; Bentivoglio A; Eleopra R; Gualberti G; Melzi G; Antonini A
    J Neurol; 2019 Sep; 266(9):2164-2176. PubMed ID: 31134377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal Vibration Training (Equistasi
    Serio F; Minosa C; De Luca M; Conte P; Albani G; Peppe A
    Sensors (Basel); 2019 May; 19(9):. PubMed ID: 31067663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease.
    Pagan FL; Hebron ML; Wilmarth B; Torres-Yaghi Y; Lawler A; Mundel EE; Yusuf N; Starr NJ; Arellano J; Howard HH; Peyton M; Matar S; Liu X; Fowler AJ; Schwartz SL; Ahn J; Moussa C
    Pharmacol Res Perspect; 2019 Apr; 7(2):e00470. PubMed ID: 30906562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 7-year observation of the effect of subthalamic deep brain stimulation on impulse control disorder in patients with Parkinson's disease.
    Kim A; Kim YE; Kim HJ; Yun JY; Yang HJ; Lee WW; Shin CW; Park H; Jung YJ; Kim A; Ehm G; Kim Y; Jang M; Jeon B
    Parkinsonism Relat Disord; 2018 Nov; 56():3-8. PubMed ID: 30054182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mirabegron in patients with Parkinson disease and overactive bladder symptoms: A retrospective cohort.
    Peyronnet B; Vurture G; Palma JA; Malacarne DR; Feigin A; Sussman RD; Biagioni MC; Palmerola R; Gilbert R; Rosenblum N; Frucht S; Kaufmann H; Nitti VW; Brucker BM
    Parkinsonism Relat Disord; 2018 Dec; 57():22-26. PubMed ID: 30037689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment and Retention in Clinical Trials of Deep Brain Stimulation in Early-Stage Parkinson's Disease: Past Experiences and Future Considerations.
    Grace Cannard K; Hacker ML; Molinari A; Heusinkveld LE; Currie AD; Charles D
    J Parkinsons Dis; 2018; 8(3):421-428. PubMed ID: 30010145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptoms and medications change patterns for Parkinson's disease patients stratification.
    Valmarska A; Miljkovic D; Konitsiotis S; Gatsios D; Lavrač N; Robnik-Šikonja M
    Artif Intell Med; 2018 Sep; 91():82-95. PubMed ID: 29803610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of motor fluctuations on real-life gait in Parkinson's patients.
    Silva de Lima AL; Evers LJW; Hahn T; de Vries NM; Daeschler M; Boroojerdi B; Terricabras D; Little MA; Bloem BR; Faber MJ
    Gait Posture; 2018 May; 62():388-394. PubMed ID: 29627498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing Efficiency of Recruitment in Early Parkinson's Disease Trials: A Case Study Examination of the STEADY-PD III Trial.
    Berk S; Greco BL; Biglan K; Kopil CM; Holloway RG; Meunier C; Simuni T
    J Parkinsons Dis; 2017; 7(4):685-693. PubMed ID: 29103052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety and effectiveness of levodopa-carbidopa intestinal gel infusion.
    De Fabregues O; Dot J; Abu-Suboh M; Hernández-Vara J; Ferré A; Romero O; Ibarria M; Seoane JL; Raguer N; Puiggros C; Gómez MR; Quintana M; Armengol JR; Alvarez-Sabín J
    Brain Behav; 2017 Aug; 7(8):e00758. PubMed ID: 28828219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.